1. Home
  2. BFS vs VIR Comparison

BFS vs VIR Comparison

Compare BFS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFS
  • VIR
  • Stock Information
  • Founded
  • BFS 1993
  • VIR 2016
  • Country
  • BFS United States
  • VIR United States
  • Employees
  • BFS N/A
  • VIR N/A
  • Industry
  • BFS Real Estate Investment Trusts
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFS Real Estate
  • VIR Health Care
  • Exchange
  • BFS Nasdaq
  • VIR Nasdaq
  • Market Cap
  • BFS 830.6M
  • VIR 844.9M
  • IPO Year
  • BFS 1993
  • VIR 2019
  • Fundamental
  • Price
  • BFS $35.13
  • VIR $5.43
  • Analyst Decision
  • BFS Strong Buy
  • VIR Strong Buy
  • Analyst Count
  • BFS 1
  • VIR 7
  • Target Price
  • BFS $45.50
  • VIR $32.86
  • AVG Volume (30 Days)
  • BFS 66.5K
  • VIR 1.1M
  • Earning Date
  • BFS 07-31-2025
  • VIR 07-31-2025
  • Dividend Yield
  • BFS 6.71%
  • VIR N/A
  • EPS Growth
  • BFS N/A
  • VIR N/A
  • EPS
  • BFS 1.47
  • VIR N/A
  • Revenue
  • BFS $274,011,000.00
  • VIR $20,861,000.00
  • Revenue This Year
  • BFS $7.78
  • VIR N/A
  • Revenue Next Year
  • BFS $6.78
  • VIR N/A
  • P/E Ratio
  • BFS $23.61
  • VIR N/A
  • Revenue Growth
  • BFS 5.04
  • VIR N/A
  • 52 Week Low
  • BFS $31.25
  • VIR $4.32
  • 52 Week High
  • BFS $42.39
  • VIR $14.45
  • Technical
  • Relative Strength Index (RSI)
  • BFS 57.44
  • VIR 56.02
  • Support Level
  • BFS $33.50
  • VIR $4.91
  • Resistance Level
  • BFS $34.69
  • VIR $5.35
  • Average True Range (ATR)
  • BFS 0.85
  • VIR 0.26
  • MACD
  • BFS -0.02
  • VIR 0.02
  • Stochastic Oscillator
  • BFS 83.16
  • VIR 98.11

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: